Implementation Facilitation of Exercise is Medicine Greenville
This study, called "Implementation Facilitation of Exercise is Medicine Greenville" (EIMG), is looking at how to better integrate physical activity into healthcare. It focuses on improving how 35 Prisma Health primary care clinics identify patients with conditions like physical inactivity, high cholesterol (dyslipidemia), obesity, high blood pressure (hypertension), and diabetes, and then refer them to community-based physical activity programs. The study will provide tailored support to these clinics over time. Success will be measured by how well the EIMG program is put into practice at the clinics and how many patients receive referrals. The study is currently unclear about its status and aims to enroll 35 clinics.
- Study design
- This is a single-arm interventional study focusing on clinic-level implementation. It involves 35 Prisma Health primary care clinics.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints will be measured from the start of pre-implementation activities to the end of Wave 4 post-implementation facilitation, with timeframes ranging from 21 to 39 months for different waves.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Implementation Facilitation of Exercise is Medicine Greenville
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jennifer L Trilk, PhD · PRINCIPAL_INVESTIGATOR · University of South Carolina School of Medicine, Greenville
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Clinic-level differences in implementation of EIMG and reach of patients receiving EIMG referrals pre- and post-implementation facilitationFrom Wave 1 start in pre-implementation facilitation activities to the end of Wave 4 post-implementation facilitation. Time frame for Wave 1 = 39 months, Wave 2 = 33 months, Wave 3 = 27 months, Wave 4 = 21 months.
Reach (primary study outcome measure) will be assessed by estimating the number and proportion of eligible patient visits engaged in EIMG by providers. A patient's visit will be considered 'engaged' if they receive an EIMG referral. The proportion is estimated by dividing patient visits with an EIMG referral by all eligible patient visits. Reach will be calculated by provider and aggregated at the clinic level. Adoption will be assessed at the provider level by determining the number, proportion, and representativeness (i.e., sex, age, specialty) of providers that utilize any EIMG component in their practice compared to peers that do not use EIMG. Implementation will be assessed by determining the extent to which all three steps of EIMG (i.e., assessment, prescription, patient referral) are conducted with each eligible patient at the provider level, aggregated at the clinic level.